BioLineRx to Report First Quarter 2026 Results on May 27, 2026
Go back to BioLineRx to Report First Quarter 2026 Results on May 27, 2026| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.79 +0.15 (5.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $1.63 | |||
| Open | $2.67 | 52 Week Low | $0.71 | |||
| Day High | $2.83 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 7,041 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.79 +0.15 (5.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $1.63 | |||
| Open | $2.67 | 52 Week Low | $0.71 | |||
| Day High | $2.83 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 7,041 | |||||

